Reovirus oncolysis-Role of cyclin-dependent kinase inhibitor 1

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer cell & microenvironment

• Publication date

  2015-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14800/CCM.750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan

  2014cited by this paper
• Reovirus: A Targeted Therapeutic—Progress And Potential

  2012cited by this paper
• Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma

  2012cited by this paper
• Mitochondrial localization of viral proteins as a means to subvert host defense.

  2011cited by this paper
• Chemoprevention: First line of defence

  2011cited by this paper
• Roles of EGFR and KRAS Mutations in the Treatment Of Patients With Non-Small-Cell Lung Cancer.

  2011cited by this paper
• Quantitative methods for assessing drug synergism.

  2011cited by this paper
• From Touchdown to Transcription: The Reovirus Cell Entry Pathway

  2010cited by this paper
• Caspase-3 activation is required for reovirus-induced encephalitis in vivo

  2010cited by this paper
• Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

  2007cited by this paper
• Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy.

  2006cited by this paper
• Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer

  2005cited by this paper
• Connecting Reovirus Oncolysis and Ras Signaling

  2005cited by this paper
• Poly(ADP-ribose) Reactivates Stalled DNA Topoisomerase I and Induces DNA Strand Break Resealing*

  2004cited by this paper
• Human Proliferating Cell Nuclear Antigen, Poly(ADP-ribose) Polymerase-1, and p21waf1/cip1

  2003influential reference
• The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

  2002influential reference
• The proteasome: a novel target for cancer chemotherapy

  2002cited by this paper
• Molecular interactions between poly(ADP‐ribose) polymerase (PARP I) and topoisomerase I (Topo I): identification of topology of binding

  2001cited by this paper
• Involvement of the Interaction between p21 and Proliferating Cell Nuclear Antigen for the Maintenance of G2/M Arrest after DNA Damage*

  2001cited by this paper
• Reovirus as a novel oncolytic agent.

  2000cited by this paper
• Viruses and cancer.

  1999cited by this paper
• Reovirus therapy of tumors with activated Ras pathway.

  1998cited by this paper
• Different Subcellular Distribution of Caspase-3 and Caspase-7 following Fas-induced Apoptosis in Mouse Liver*

  1998cited by this paper
• The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

  1998cited by this paper
• Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control.

  1997cited by this paper
• Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

  1996cited by this paper
• Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

  1995cited by this paper
• Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.

  1995cited by this paper
• Viruses and cancer.

  1991cited by this paper
• ADP-ribosylation of ADPR-transferase and topoisomerase I in intact mouse epidermal cells JB6.

  1989cited by this paper

• No citing papers are available for this paper.